vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Ouster, Inc. (OUST). Click either name above to swap in a different company.
Ouster, Inc. is the larger business by last-quarter revenue ($62.2M vs $47.7M, roughly 1.3× IRONWOOD PHARMACEUTICALS INC). On growth, Ouster, Inc. posted the faster year-over-year revenue change (106.6% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-37.2M). Over the past eight quarters, Ouster, Inc.'s revenue compounded faster (54.8% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
IRWD vs OUST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $62.2M |
| Net Profit | $-2.3M | — |
| Gross Margin | — | 60.2% |
| Operating Margin | 14.3% | 1.5% |
| Net Margin | -4.8% | — |
| Revenue YoY | -47.3% | 106.6% |
| Net Profit YoY | -200.9% | — |
| EPS (diluted) | $0.01 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $62.2M | ||
| Q3 25 | $122.1M | $39.5M | ||
| Q2 25 | $85.2M | $35.0M | ||
| Q1 25 | $41.1M | $32.6M | ||
| Q4 24 | $90.5M | $30.1M | ||
| Q3 24 | $91.6M | $28.1M | ||
| Q2 24 | $94.4M | $27.0M | ||
| Q1 24 | $74.9M | $25.9M |
| Q4 25 | $-2.3M | — | ||
| Q3 25 | $40.1M | $-21.7M | ||
| Q2 25 | $23.6M | $-20.6M | ||
| Q1 25 | $-37.4M | $-22.0M | ||
| Q4 24 | $2.3M | — | ||
| Q3 24 | $3.6M | $-25.6M | ||
| Q2 24 | $-860.0K | $-23.9M | ||
| Q1 24 | $-4.2M | $-23.8M |
| Q4 25 | — | 60.2% | ||
| Q3 25 | — | 42.1% | ||
| Q2 25 | — | 45.2% | ||
| Q1 25 | — | 41.3% | ||
| Q4 24 | — | 43.8% | ||
| Q3 24 | — | 38.3% | ||
| Q2 24 | — | 33.7% | ||
| Q1 24 | — | 28.6% |
| Q4 25 | 14.3% | 1.5% | ||
| Q3 25 | 61.8% | -61.4% | ||
| Q2 25 | 53.2% | -76.5% | ||
| Q1 25 | -70.7% | -73.0% | ||
| Q4 24 | 34.8% | -85.1% | ||
| Q3 24 | 28.0% | -98.0% | ||
| Q2 24 | 26.5% | -93.6% | ||
| Q1 24 | 14.7% | -99.5% |
| Q4 25 | -4.8% | — | ||
| Q3 25 | 32.8% | -55.0% | ||
| Q2 25 | 27.7% | -58.8% | ||
| Q1 25 | -90.9% | -67.5% | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 4.0% | -91.1% | ||
| Q2 24 | -0.9% | -88.4% | ||
| Q1 24 | -5.6% | -91.9% |
| Q4 25 | $0.01 | $0.10 | ||
| Q3 25 | $0.23 | $-0.37 | ||
| Q2 25 | $0.14 | $-0.38 | ||
| Q1 25 | $-0.23 | $-0.42 | ||
| Q4 24 | $0.03 | $-0.46 | ||
| Q3 24 | $0.02 | $-0.54 | ||
| Q2 24 | $-0.01 | $-0.53 | ||
| Q1 24 | $-0.03 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $208.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $261.7M |
| Total Assets | $396.9M | $349.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $208.6M | ||
| Q3 25 | $140.4M | $244.5M | ||
| Q2 25 | $92.9M | $226.5M | ||
| Q1 25 | $108.5M | $168.2M | ||
| Q4 24 | $88.6M | $172.0M | ||
| Q3 24 | $88.2M | $151.4M | ||
| Q2 24 | $105.5M | $184.2M | ||
| Q1 24 | $121.5M | $187.8M |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $261.7M | ||
| Q3 25 | $-264.2M | $247.4M | ||
| Q2 25 | $-308.2M | $221.0M | ||
| Q1 25 | $-334.1M | $167.9M | ||
| Q4 24 | $-301.3M | $180.9M | ||
| Q3 24 | $-311.3M | $171.7M | ||
| Q2 24 | $-321.7M | $170.6M | ||
| Q1 24 | $-330.5M | $167.2M |
| Q4 25 | $396.9M | $349.5M | ||
| Q3 25 | $396.1M | $353.8M | ||
| Q2 25 | $342.9M | $321.8M | ||
| Q1 25 | $327.2M | $268.6M | ||
| Q4 24 | $350.9M | $276.1M | ||
| Q3 24 | $389.5M | $255.2M | ||
| Q2 24 | $395.6M | $309.9M | ||
| Q1 24 | $438.8M | $317.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $-15.4M |
| Free Cash FlowOCF − Capex | $74.6M | $-37.2M |
| FCF MarginFCF / Revenue | 156.3% | -59.8% |
| Capex IntensityCapex / Revenue | 0.0% | 35.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $-64.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $-15.4M | ||
| Q3 25 | $47.6M | $-18.3M | ||
| Q2 25 | $-15.1M | $-1.3M | ||
| Q1 25 | $20.0M | $-4.9M | ||
| Q4 24 | $15.2M | $-2.6M | ||
| Q3 24 | $9.9M | $-3.8M | ||
| Q2 24 | $33.5M | $-21.6M | ||
| Q1 24 | $45.0M | $-5.7M |
| Q4 25 | $74.6M | $-37.2M | ||
| Q3 25 | $47.6M | $-20.0M | ||
| Q2 25 | $-15.1M | $-2.2M | ||
| Q1 25 | $19.9M | $-5.4M | ||
| Q4 24 | — | $-4.0M | ||
| Q3 24 | $9.9M | $-4.3M | ||
| Q2 24 | $33.4M | $-22.0M | ||
| Q1 24 | $44.9M | $-7.1M |
| Q4 25 | 156.3% | -59.8% | ||
| Q3 25 | 39.0% | -50.7% | ||
| Q2 25 | -17.7% | -6.3% | ||
| Q1 25 | 48.4% | -16.6% | ||
| Q4 24 | — | -13.3% | ||
| Q3 24 | 10.8% | -15.4% | ||
| Q2 24 | 35.4% | -81.5% | ||
| Q1 24 | 60.0% | -27.4% |
| Q4 25 | 0.0% | 35.0% | ||
| Q3 25 | 0.0% | 4.3% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.1% | 1.7% | ||
| Q4 24 | 0.0% | 4.8% | ||
| Q3 24 | 0.0% | 2.0% | ||
| Q2 24 | 0.1% | 1.3% | ||
| Q1 24 | 0.1% | 5.3% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
